California BanCorp (BCAL) fair value analysis
Nasdaq · Updated 2026-10-19
BCAL price how computed
Forward Fair Value verdict
OvervaluedBCAL is trading at a 10–25% premium to estimated fair value.
Based on TickrTrends' weekly Forward Fair Value model.
- Last price
- $21.76
- Sector
- Financial Services
- 12-month range
- $17.21–$22.09
- Market cap
- $700M
- From 52-week high
- -1.5%
- Shares outstanding
- 32.2M
- Rank in Financial Services by discount to fair value
- #122 of 167
Last price is our stored weekly price from 2026-10-16, older than the 2026-10-19 run that built this page; the chart runs through 2026-10-16.
California BanCorp is a bank holding company that provides banking and financial services through its subsidiary banks. The company operates primarily in California, serving customers through branch networks in the state.
BCAL currently ranks #122 of 167 Financial Services stocks by discount to fair value. It has screened as Overvalued for 6 consecutive weekly runs.
Fundamentals (4 quarters) how computed
- Market cap
- $700M
- P/E (trailing)
- 12x
- Revenue (TTM)
- $231M
- Net margin
- 26.0%
- EPS (TTM)
- $1.84
- Gross margin
- 78.2%
- Debt / equity
- 0.09
- Revenue growth (3-yr avg)
- 24.8%
- Shares outstanding
- 32.2M
Derived indicators how computed
- Quality grade
- A
- Margin trend
- Expanding
- 52-week position
- The top quarter of its range
Technicals how computed
- RSI (14-day)
- 53 · neutral
- 50-day average
- $21.55
- 200-day average
- $19.71
- Moving-average state
- 50-day above 200-day (golden cross state); price above both averages
Dividends how computed
- Paid, last 12 months
- $0.42 per share (4 payments)
- Yield on last price
- 1.93%
- Consecutive years of increases
- 0 (no streak on complete calendar years)
- Last ex-dividend date
- 2026-09-21
- Last payment date
- 2026-10-15
Earnings how computed
- Next earnings report
- 2026-10-27
- Last 8 quarters vs consensus
- 8 beat, 0 missed
- Quarter by quarter
- 2026-06 ▲ beat (+7.3%)
2026-03 ▲ beat (+2.4%)
2025-12 ▲ beat (+16.3%)
2025-09 ▲ beat (+23.1%)
2025-06 ▲ beat (+4.9%)
2025-03 ▲ beat (+30.0%)
2024-12 ▲ beat (+20.5%)
2024-09 ▲ beat (+37.5%)
Analyst consensus how computed
This is not TickrTrends' verdict.
- Analyst ratings
- 4 buy · 0 hold · 0 sell (4 analysts)
- Consensus lean
- Buy-leaning
- Consensus price target
- $24.8
- Target vs last price
- +14.0%
What our data shows for BCAL
- Our model validated 17 trailing price-to-earnings windows for BCAL, built from quarterly earnings records.
- Shares are trading in the upper third of their 12-month price range of $17.21–$22.09.
- The 14-day relative strength index sits at a neutral 53.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for BCAL
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
Forward Fair Value applies a conservatively normalized historical price-to-earnings multiple to the consensus earnings estimate for the next full fiscal year; how TickrTrends computes it.
What people are saying
Follow the BCAL conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-10-19 — BCAL's sector discount rank declined this week, moving from #124 to #130 among Financial Services companies, indicating a weaker relative valuation position within its peer group. The stock maintains an overvalued status according to TickrTrends' derived indicators. This shift suggests BCAL has become less attractively valued compared to other firms in the Financial Services sector.
- 2026-10-12 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-11 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-10 — No material change this week: the verdict, bands and grades all held steady.
- 2026-10-05 — # BCAL Weekly Indicator Summary TickrTrends' derived indicators show that BCAL has moved to a worse position relative to its sector peers this week, with its sector discount rank declining from #119 to #125, indicating the stock has become less attractively valued compared to other Financial Services companies. The current valuation verdict remains Overvalued, suggesting the stock is trading at a premium relative to its fundamentals.
- 2026-09-28 — BCAL's position within the Financial Services sector has shifted this week. The company's sector discount rank declined from 110 to 119, indicating a weaker relative valuation standing among peers. The valuation verdict changed from Fairly valued to Overvalued according to TickrTrends' derived indicators.
- 2026-09-21 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-17 — No material change this week: the verdict, bands and grades all held steady.
Frequently asked questions
Is BCAL stock undervalued?
Based on TickrTrends' Forward Fair Value model (updated 2026-10-19), BCAL is trading at a 10–25% premium to estimated fair value and screens as overvalued. The exact fair value and discount are available to subscribers.
What is BCAL's TickrTrends verdict?
BCAL's current verdict is Overvalued, refreshed with every weekly Forward Fair Value run.
How does BCAL compare to other Financial Services stocks?
BCAL ranks #122 of 167 Financial Services stocks in TickrTrends' coverage by discount to fair value.
Is BCAL overbought or oversold?
BCAL's 14-day RSI is in neutral territory - neither overbought nor oversold.
Does BCAL pay a dividend?
Yes. BCAL paid $0.42 per share over the last twelve months (4 payments), a 1.93% yield on TickrTrends' last price. The last ex-dividend date was 2026-09-21.
When does BCAL report earnings next?
BCAL's next earnings report is scheduled for 2026-10-27, per the published earnings calendar.
Does BCAL usually beat earnings estimates?
Over its last 8 reported quarters BCAL beat the consensus estimate 8 times and missed 0 times, by TickrTrends' comparison of reported and estimated EPS.
What do analysts say about BCAL?
Of 4 analysts covering BCAL, 4 rate it a buy, 0 a hold and 0 a sell - buy-leaning, with a consensus price target of $24.8 (+14.0% versus TickrTrends' last price). This is the analyst consensus, not TickrTrends' Forward Fair Value verdict.
More in Financial Services
Head-to-head comparisons
BCAL vs AFL · BCAL vs CHCO · BCAL vs EFSC · BCAL vs FBNC · BCAL vs FMBH